Team

Bill Ericson
General Partner, MDV-Mohr Davidow Ventures

Bill Ericson joined MDV in 2000 after more than a decade of working closely with entrepreneurs to start and build innovative businesses in the role of lawyer, board member, entrepreneur and investor. Bill's investment focus at MDV is primarily in life sciences, with a current specific focus on molecular diagnostics and platforms that will enable the vision of personalized medicine. He works closely with a cross-disciplinary team of leading scientists, researchers and entrepreneurs, and seeks to apply technology solutions to life sciences in non-traditional ways. Bill has also led investments in a number of information technology and Internet companies.

In addition to serving on the board of Pacific Biosciences Bill is also on the board of Adamas Pharmaceuticals, Artemis Health, Cellpoint Diagnostics, nLight Photonics, RainDance Technologies, Revenue Science, Sabrix, Tethys Bioscience and Visible Measures.

Prior to MDV Bill founded and ran Venture Law Group's Seattle office. Bill is particularly proud of being a member of the founding team of Rosetta Inpharmatics and serving on its Board of Directors until its acquisition by Merck in 2001.

Bill serves on the Board of Northwestern University School of Law and is a member of the Personalized Medicine Coalition. Bill received his B.S.F.S. from Georgetown University of Foreign Service and J.D. from Northwestern University School of Law.